Cargando…

SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells

SLAMF1 is often overexpressed in Epstein Barr virus (EBV)-infected B cell tumors. However, its role in the pathogenesis of EBV-infected B cell tumors remains largely unknown. Here, we generated SLAMF1-deficient EBV+ tumor cells and examined the effect of its deficiency on cell proliferation and cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Heejei, Kim, Eung Kweon, Ko, Young Hyeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473542/ https://www.ncbi.nlm.nih.gov/pubmed/32886706 http://dx.doi.org/10.1371/journal.pone.0238791

Ejemplares similares

LMP1(+)SLAMF1(high) cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells
por: Yoon, Heejei, et al.
Publicado: (2017)

CRISPR-Mediated Triple Knockout of SLAMF1, SLAMF5 and SLAMF6 Supports Positive Signaling Roles in NKT Cell Development
por: Huang, Bonnie, et al.
Publicado: (2016)

An improved radiosynthesis of [(18)F]FAraG, a PET radiotracer for imaging T‐cell activation
por: Holt, Daniel P., et al.
Publicado: (2022)

Negative Regulation of Humoral Immunity Due to Interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors
por: Wang, Ninghai, et al.
Publicado: (2015)

Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8
por: Wang, Guoxing, et al.
Publicado: (2015)

Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines
por: Yoon, Heejei, et al.
Publicado: (2014)

Translation and Validation of the Farage Quality of Life (FQoL™) Instrument for Consumer Products into Traditional Chinese
por: Farage, Miranda A., et al.
Publicado: (2013)

SLAMF6 compartmentalization enhances T cell functions
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2022)

CRISPR-Mediated Slamf1(Δ/Δ) Slamf5(Δ/Δ) Slamf6(Δ/Δ) Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects
por: Hu, Joyce K., et al.
Publicado: (2016)

SLAMF6 clustering is required to augment T cell activation
por: Dragovich, Matthew A., et al.
Publicado: (2019)

Longitudinal Imaging of T Cells and Inflammatory Demyelination in a Preclinical Model of Multiple Sclerosis Using (18)F-FAraG PET and MRI
por: Guglielmetti, Caroline, et al.
Publicado: (2022)

The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5
por: Radomir, Lihi, et al.
Publicado: (2021)

Responses to Microbial Challenges by SLAMF Receptors
por: van Driel, Boaz Job, et al.
Publicado: (2016)

Upregulation of SLAMF3 on human T cells is induced by palmitic acid through the STAT5-PI3K/Akt pathway and features the chronic inflammatory profiles of type 2 diabetes
por: Zhou, Tong, et al.
Publicado: (2019)

SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors
por: De Calisto, Jaime, et al.
Publicado: (2014)

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
por: He, Yuan, et al.
Publicado: (2019)

SLAMF1 Promotes Methotrexate Resistance via Activating Autophagy in Choriocarcinoma Cells
por: Shi, Dazun, et al.
Publicado: (2020)

Activation of the Akt Survival Pathway Contributes to TRAIL Resistance in Cancer Cells
por: Xu, Jing, et al.
Publicado: (2010)

RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation
por: Bouhlal, Hicham, et al.
Publicado: (2016)

SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity
por: O’Connell, Patrick, et al.
Publicado: (2022)

Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition
por: Fouquet, Grégory, et al.
Publicado: (2022)

SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2
por: von Wenserski, Lisa, et al.
Publicado: (2020)

The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells
por: Wang, Yufeng, et al.
Publicado: (2018)

SLAMF8 Downregulates Mouse Macrophage Microbicidal Mechanisms via PI3K Pathways
por: Romero-Pinedo, Salvador, et al.
Publicado: (2022)

SLAMF1 is required for TLR4-mediated TRAM-TRIF–dependent signaling in human macrophages
por: Yurchenko, Maria, et al.
Publicado: (2018)

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
por: Einsele, Hermann, et al.
Publicado: (2016)

Clinical impact of serum soluble SLAMF7 in multiple myeloma
por: Ishibashi, Mariko, et al.
Publicado: (2018)

The Receptor Slamf1 on the Surface of Myeloid Lineage Cells Controls Susceptibility to Infection by Trypanosoma cruzi
por: Calderón, Jossela, et al.
Publicado: (2012)

Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression
por: Marcq, Ingrid, et al.
Publicado: (2013)

The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis
por: Gonçalves-Carneiro, Daniel, et al.
Publicado: (2017)

Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma
por: Friend, Reed, et al.
Publicado: (2017)

SLAMF6 is associated with the susceptibility and severity of rheumatoid arthritis in the Chinese population
por: Xia, Guodong, et al.
Publicado: (2022)

SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis
por: Wu, Yongjian, et al.
Publicado: (2023)

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments
por: Chu, Emily, et al.
Publicado: (2023)

Gut symbiotic microbes imprint intestinal immune cells with the innate receptor SLAMF4 which contributes to gut immune protection against enteric pathogens
por: Cabinian, Allison, et al.
Publicado: (2018)

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
por: Campbell, Kerry S., et al.
Publicado: (2018)

Licochalcone D Inhibits Skin Epidermal Cells Transformation through the Regulation of AKT Signaling Pathways
por: Hwang, Sun-Young, et al.
Publicado: (2023)

SLAMF8 Participates in Acute Renal Transplant Rejection via TLR4 Pathway on Pro-Inflammatory Macrophages
por: Teng, Lisha, et al.
Publicado: (2022)

Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling
por: Taniwaki, Masafumi, et al.
Publicado: (2018)

Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway
por: Gao, Shangfeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_30mf0o18lep3ce1gbfa9ejtljc